84 related articles for article (PubMed ID: 20488577)
1. Pemetrexed-induced edema of the eyelid.
Guhl G; Diaz-Ley B; Sanchez-Perez J; Jimenez U; Garcia-Diez A
Lung Cancer; 2010 Aug; 69(2):249-50. PubMed ID: 20488577
[No Abstract] [Full Text] [Related]
2. Pemetrexed-induced eyelid edema: incidence and clinical manifestations.
Schallier D; Decoster L; Fontaine C; De Grève J
Anticancer Res; 2010 Dec; 30(12):5185-8. PubMed ID: 21187510
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed-induced edema of the eyelid.
Kurata T; Tamura K; Okamoto I; Satoh T; Nakagawa K; Fukuoka M
Lung Cancer; 2006 Nov; 54(2):241-2. PubMed ID: 16996165
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.
Karapanagiotou EM; Boura PG; Papamichalis G; Konstantinou M; Sepsas E; Chamalakis G; Simsiris P; Gkiozos I; Syrigos KN
Anticancer Res; 2009 Oct; 29(10):4297-301. PubMed ID: 19846990
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
Smit EF; Burgers SA; Biesma B; Smit HJ; Eppinga P; Dingemans AM; Joerger M; Schellens JH; Vincent A; van Zandwijk N; Groen HJ
J Clin Oncol; 2009 Apr; 27(12):2038-45. PubMed ID: 19307503
[TBL] [Abstract][Full Text] [Related]
6. A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer.
Scagliotti GV; Germonpré P; Bosquée L; Vansteenkiste J; Gervais R; Planchard D; Reck M; De Marinis F; Lee JS; Park K; Biesma B; Gans S; Ramlau R; Szczesna A; Makhson A; Manikhas G; Morgan B; Zhu Y; Chan KC; von Pawel J
Lung Cancer; 2010 Jun; 68(3):420-6. PubMed ID: 19692142
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer.
Kim HS; Lee GW; Kim JH; Kim HY; Kwon JH; Song HH; Kim HJ; Jung JY; Jang G; Choi DR; Park SM; Shin TR; Lee HS; Zang DY
Lung Cancer; 2010 Oct; 70(1):71-6. PubMed ID: 20096475
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
[TBL] [Abstract][Full Text] [Related]
9. Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization.
Ambika S; Melton A; Lee D; Hesketh PJ
Clin Lung Cancer; 2009 Sep; 10(5):E1-4. PubMed ID: 19808165
[TBL] [Abstract][Full Text] [Related]
10. Painful generalized erythematous patches: a severe and unusual cutaneous reaction to pemetrexed.
Vitiello M; Romanelli P; Kerdel FA
J Am Acad Dermatol; 2011 Jul; 65(1):243-4. PubMed ID: 21679840
[No Abstract] [Full Text] [Related]
11. Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.
Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A
Lung Cancer; 2009 Aug; 65(2):251-3. PubMed ID: 19346026
[TBL] [Abstract][Full Text] [Related]
12. Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
Scagliotti GV; Kortsik C; Dark GG; Price A; Manegold C; Rosell R; O'Brien M; Peterson PM; Castellano D; Selvaggi G; Novello S; Blatter J; Kayitalire L; Crino L; Paz-Ares L
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):690-6. PubMed ID: 15701857
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed-induced eyelid edema in lung cancer.
Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
[TBL] [Abstract][Full Text] [Related]
14. Asteatotic eczema ('eczema craquelé') with histopathological interface dermatitis: a new cutaneous reaction following pemetrexed.
Frouin E; Sebille G; Freudenberger S; Menecier B; Quoix E; Cribier B; Lipsker D
Br J Dermatol; 2012 Jun; 166(6):1359-60. PubMed ID: 22182200
[No Abstract] [Full Text] [Related]
15. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
Zinner RG; Fossella FV; Gladish GW; Glisson BS; Blumenschein GR; Papadimitrakopoulou VA; Pisters KM; Kim ES; Oh YW; Peeples BO; Ye Z; Curiel RE; Obasaju CK; Hong WK; Herbst RS
Cancer; 2005 Dec; 104(11):2449-56. PubMed ID: 16258975
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: a phase I-II trial.
Stathopoulos GP; Dimitroulis J; Toubis M; Katis C; Karaindros D; Stathopoulos J; Koutandos J
Lung Cancer; 2007 Jul; 57(1):66-71. PubMed ID: 17382431
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Imai H; Utsugi M; Iwasaki Y; Shimizu K; Iijima H; Tsurumaki H; Tomizawa Y; Hisada T; Ishizuka T; Saito R; Mori M
Lung Cancer; 2010 May; 68(2):253-7. PubMed ID: 19631403
[TBL] [Abstract][Full Text] [Related]
19. Activity of pemetrexed on brain metastases from non-small cell lung cancer: what is the mechanism?
Dogan M; Yalcin B; Utkan G; Urun Y; Ozal G
Lung Cancer; 2009 Dec; 66(3):399. PubMed ID: 19783320
[No Abstract] [Full Text] [Related]
20. Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.
Ferraldeschi R; Thatcher N; Lorigan P
Expert Rev Anticancer Ther; 2007 May; 7(5):635-40. PubMed ID: 17492928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
